Clear Search

Showing 2 result for “Cappelleri JC”.

乾癬性関節炎患者におけrトファシチニブ治療による疼痛改善までの時間とベースライン時の疼痛重症度が反応性におよぼす影響

RMD Open. 2021;7(2):e001609.

Tofacitinib 5 mg twice daily provides clinically meaningful improvements in pain for patients with PsA.Reducing pain is a primary treatment concern for patients with PsA. As such, de Vlam, et al. set out to evaluate the time to pain improvement and the impact of baseline pain severity on pain response in patients with PsA receiving tofacitinib.Using data from the OPAL Broaden and OPAL Beyond trials, they discovered that clinically important improvements in pain were experienced by more patients,...

続きを読む…